A brand new report inspecting innovation discovered that among the many 100 most progressive firms, the biggest quantity — 18 — had been within the pharmaceutical business.

Giant pharmas together with Bristol-Myers Squibb (NYSE:BMY), Eli Lilly (LLY), Johnson & Johnson (NYSE:JNJ), Novartis (NVS), Pfizer (NYSE:PFE), Roche (OTCQX:RHHBY), and Sanofi (SNY) made the listing, compiled by LexisNexis.

Amongst giant biotechs, Amgen (AMGN), Gilead Sciences (NASDAQ:GILD), Moderna (MRNA), and Regeneron (REGN) made the reduce.

Alnylam Prescription drugs (ALNY), which is concentrated on growing RNA interference (RNAi) therapeutics, and Jazz Prescription drugs (JAZZ), identified for medicines for sleep issues and epilepsy, had been new additions in 2023.

The LexisNexis report, Innovation Momentum 2023: The World High 100, lists firms with the best innovation momentum, based mostly on the Patent Asset Index, a “scientifically developed goal measure to judge progressive power.”

“An growing older international inhabitants and the lengthy tail of the COVID-19 pandemic are creating demand for brand spanking new pharmaceutical therapies and merchandise,” the report states. “This offers alternatives for small gamers with progressive applied sciences, but additionally for big firms.”

Among the many 18 pharma firms included within the report, 13 are based mostly within the US, with the remaining in Europe.

9 medtech firms additionally had been included. LexisNexis famous that these firms had been in a position to enhance their patent portfolio dimension in addition to keep or enhance the scale of these portfolios.

Whereas medtech firms have similarities by way of patent portfolio development and geographic areas, they differ tremendously with regards to their applied sciences.

The report notes that Medtronic (MDT) has the biggest patent portfolio. Its “applied sciences allow the whole lot from digital diabetes monitoring to minimally invasive surgical procedure and tiny leadless pacemakers that may be implanted instantly into the center.”

LexisNexis mentioned that the ResMed (RMD), identified for its ventilators and CPAP units used for sleep apnea, noticed its patent high quality enhance in recent times because of its units elevated use throughout the COVID-19 pandemic.

One other medtech making the listing is Align Know-how (ALGN), identified for its clear enamel aligners. “By specializing in one sort of system, it has been in a position to enhance its common patent high quality on a constant foundation.”

LexisNexis additionally highlighted Becton, Dickinson (BDX), Edwards Lifesciences (EW), Intuitive Surgical (ISRG), and Stryker (SYK) as different progressive medtechs with sturdy patent portfolios.